From: Azithromycin in Chronic Fatigue Syndrome (CFS), an analysis of clinical data
 | Non responders | Responders | P |
---|---|---|---|
 | Mean (SD) | Mean (SD) |  |
Age (y) | 40.3 (12.7) | 34.7 (11.5) | 0.023 |
MFI-20: General fatigue | 19.1 (1.4) | 18.7 (1.8) | 0.267 |
MFI-20: Physical fatigue | 18.0 (2.3) | 17.7 (2.7) | 0.532 |
MFI-20: Mental fatigue | 16.4 (3.4) | 15.2 (4.2) | 0.112 |
MFI-20: Activity | 15.5 (3.3) | 15.1 (3.8) | 0.595 |
MFI-20: Motivation | 11.0 (4.3) | 10.1 (3.6) | 0.283 |
4DSQ: Somatisation | 0.91 (0.42) | 1.11 (1.03) | 0.258 |
4DSQ: Distress | 0.89 (0.54) | 0.91 (0.51) | 0.859 |
4DSQ: Depression | 0.30 (0.47) | 0.35 (0.49) | 0.585 |
4DSQ: Anxiety | 0.28 (0.35) | 0.33 (0.38) | 0.481 |
Pain VAS score | 27.8 (23.3) | 26.8 (24.2) | 0.888 |
Stanford HAQ | 1.15 (0.19) | 1.14 (0.28) | 0.957 |